Literature DB >> 28958800

Predicting progression in patients with Parkinson's disease.

Cornelis Blauwendraat1, Sara Bandrés-Ciga2, Andrew B Singleton3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28958800      PMCID： PMC6005700          DOI： 10.1016/S1474-4422(17)30331-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  9 in total

1.  Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.

Authors:  Bernard Ravina; Kenneth Marek; Shirley Eberly; David Oakes; Roger Kurlan; Alberto Ascherio; Flint Beal; James Beck; Emily Flagg; Wendy R Galpern; Jennifer Harman; Anthony E Lang; Michael Schwarzschild; Caroline Tanner; Ira Shoulson
Journal:  Mov Disord       Date:  2012-09-13       Impact factor: 10.338

Review 2.  The Parkinson Progression Marker Initiative (PPMI).

Authors: 
Journal:  Prog Neurobiol       Date:  2011-09-14       Impact factor: 10.885

3.  A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.

Authors:  Bernard Ravina; Caroline Tanner; Diane Dieuliis; Shirley Eberly; Emily Flagg; Wendy R Galpern; Stanley Fahn; Christopher G Goetz; Stephen Grate; Roger Kurlan; Anthony E Lang; Kenneth Marek; Karl Kieburtz; David Oakes; Robin Elliott; Ira Shoulson
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

4.  Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).

Authors:  Mike A Nalls; Margaux F Keller; Dena G Hernandez; Lan Chen; David J Stone; Andrew B Singleton
Journal:  Mov Disord       Date:  2015-08-13       Impact factor: 10.338

5.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

6.  Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.

Authors:  Mike A Nalls; Cory Y McLean; Jacqueline Rick; Shirley Eberly; Samantha J Hutten; Katrina Gwinn; Margaret Sutherland; Maria Martinez; Peter Heutink; Nigel M Williams; John Hardy; Thomas Gasser; Alexis Brice; T Ryan Price; Aude Nicolas; Margaux F Keller; Cliona Molony; J Raphael Gibbs; Alice Chen-Plotkin; Eunran Suh; Christopher Letson; Massimo S Fiandaca; Mark Mapstone; Howard J Federoff; Alastair J Noyce; Huw Morris; Vivianna M Van Deerlin; Daniel Weintraub; Cyrus Zabetian; Dena G Hernandez; Suzanne Lesage; Meghan Mullins; Emily Drabant Conley; Carrie A M Northover; Mark Frasier; Ken Marek; Aaron G Day-Williams; David J Stone; John P A Ioannidis; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2015-08-10       Impact factor: 44.182

7.  Imaging genetics approach to Parkinson's disease and its correlation with clinical score.

Authors:  Mansu Kim; Jonghoon Kim; Seung-Hak Lee; Hyunjin Park
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

8.  Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.

Authors:  Jeanne C Latourelle; Michael T Beste; Tiffany C Hadzi; Robert E Miller; Jacob N Oppenheim; Matthew P Valko; Diane M Wuest; Bruce W Church; Iya G Khalil; Boris Hayete; Charles S Venuto
Journal:  Lancet Neurol       Date:  2017-09-25       Impact factor: 44.182

9.  Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.

Authors:  Marie Y Davis; Catherine O Johnson; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Alice Chen-Plotkin; Vivianna M Van Deerlin; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Liana S Rosenthal; Ted M Dawson; Marilyn S Albert; Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson; David Eidelberg; Paul J Mattis; Martin Niethammer; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Megan Smith; Ignacio F Mata; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302
  9 in total
  2 in total

1.  SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease.

Authors:  Rubén Fernández-Santiago; Núria Martín-Flores; Francesca Antonelli; Catalina Cerquera; Verónica Moreno; Sara Bandres-Ciga; Elisabetta Manduchi; Eduard Tolosa; Andrew B Singleton; Jason H Moore; María-Josep Martí; Mario Ezquerra; Cristina Malagelada
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

2.  The emerging postural instability phenotype in idiopathic Parkinson disease.

Authors:  Frank M Skidmore; William S Monroe; Christopher P Hurt; Anthony P Nicholas; Adam Gerstenecker; Thomas Anthony; Leon Jololian; Gary Cutter; Adil Bashir; Thomas Denny; David Standaert; Elizabeth A Disbrow
Journal:  NPJ Parkinsons Dis       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.